Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cantor Fitzgerald
McKinsey
Medtronic
Julphar
Queensland Health
Fuji
Moodys
Merck
QuintilesIMS

Generated: April 24, 2018

DrugPatentWatch Database Preview

GENTAK Drug Profile

« Back to Dashboard

When do Gentak patents expire, and when can generic versions of Gentak launch?

Gentak is a drug marketed by Akorn and is included in one NDA.

The generic ingredient in GENTAK is gentamicin sulfate. There are fifteen drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the gentamicin sulfate profile page.
Drug patent expirations by year for GENTAK
Pharmacology for GENTAK
Synonyms for GENTAK
(1R,2S,3S,4R,6S)-4,6-diamino-3-{[3-deoxy-4-C-methyl-3-(methylamino)-beta-L-arabinopyranosyl]oxy}-2-hydroxycyclohexyl (6x)-2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)-alpha-D-erythro-heptopyranoside
(2R,3R,4R,5R)-2-[(1S,2S,3R,4S,6R)-4,6-diamino-3-[(2R,3R,6S)-3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
123871-EP2292088A1
123871-EP2295422A2
123871-EP2295439A1
1403-66-3
2-[4,6-diamino-3-[3-amino-6-(1-methylaminoethyl)oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-methylaminooxane-3,5-diol
2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]oxan-2-yl]oxy-2-hydroxycyclohexyl]oxy-5-methyl-4-(methylamino)oxane-3,5-diol
2-[4,6-diamino-3-[3-amino-6-[1-(methylamino)ethyl]tetrahydropyran-2-yl]oxy-2-hydroxy-cyclohexoxy]-5-methyl-4-(methylamino)tetrahydropyran-3,5-diol
2-{[4,6-diamino-3-({3-amino-6-[1-(methylamino)ethyl]oxan-2-yl}oxy)-2-hydroxycyclohexyl]oxy}-5-methyl-4-(methylamino)oxane-3,5-diol
4,6-diamino-3-{[3-deoxy-4-c-methyl-3-(methylamino)pentopyranosyl]oxy}-2-hydroxycyclohexyl 2-amino-2,3,4,6,7-pentadeoxy-6-(methylamino)heptopyranoside
AC-13386
AC1L1G02
AC1Q57VC
AKOS015961211
Alcomicin
AN-49150
Apogen
BC657258
Bristagen
CA007545
CEAZRRDELHUEMR-UHFFFAOYSA-N
CHEMBL329592
Cidomycin
D08013
D0L9UU
DB00798
EINECS 215-765-8
FT-0626646
G-Mycin
G-Myticin
Garamycin
Garamycin (TN)
Garamycin Otic Solution
Garasol
Genoptic Liquifilm
Genoptic S.O.P.
Gentacidin
Gentacycol
Gentafair
Gentamar
Gentamcin Sulfate
gentamicin
Gentamicin (BAN)
Gentamicin (TN)
Gentamicin antibiotic complex
Gentamicin C1
Gentamicin complex consisting of factors gentamicin C1 and C2
Gentamicin sulphate sterile
Gentamicina
Gentamicina [INN-Spanish]
Gentamicine
Gentamicine [INN-French]
Gentamicins
Gentamicinum
Gentamicinum [INN-Latin]
GENTAMYCIN
Gentamycin-creme
Gentamycin-creme [German]
gentamycine
Gentamycinum
gentamysinsolutionforbiochemistry
Gentavet
Gentocin
GTPL2427
HE069863
HSDB 3087
Jenamicin
LS-71146
Ocu-Mycin
Refobacin
Refobacin TM
SCHEMBL537630
Spectro-Genta
STL454325
U-Gencin
Uromycine

US Patents and Regulatory Information for GENTAK

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Akorn GENTAK gentamicin sulfate SOLUTION/DROPS;OPHTHALMIC 064163-001 Oct 12, 2001 AT RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Queensland Health
Cipla
Teva
Healthtrust
Deloitte
Harvard Business School
AstraZeneca
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.